5:41 PM
 | 
Oct 19, 2012
 |  BC Extra  |  Financial News

Cleveland BioLabs adds $15 million

Cleveland BioLabs Inc. (NASDAQ:CBLI) raised $15 million through the sale of 7.5 million units at $2 in a follow-on underwritten by Oppenheimer; Cantor Fitzgerald; and Ladenburg Thalmann. Burrill was financial advisor. Each unit comprises...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >